Pulmonary Surfactant: Six Critical Functions in Lung Mechanics and Immunity

Pulmonary surfactant is a complex lipoprotein mixture (90% lipids—mostly dipalmitoylphosphatidylcholine, 10% proteins—SP-A, B, C, D) secreted by alveolar type II pneumocytes. It is indispensable for respiratory mechanics and host defense.

Six Critical Functions

1. Reduces Surface Tension: By adsorbing at the air-liquid interface, surfactant lowers surface tension from ~70 to near 0 mN/m at low lung volumes. This prevents alveolar collapse (atelectasis) at end-exhalation—the primary mechanical role.
2. Enhances Lung Compliance: Lower surface tension reduces the pressure needed to inflate alveoli (ΔP = 2T/r). Work of breathing decreases dramatically.
3. Prevents Atelectasis: Stabilizes small alveoli (which would otherwise collapse disproportionately by Laplace's law), maintaining uniform ventilation.
4. Immunological Defense: SP-A and SP-D (collectins) opsonize pathogens, enhance macrophage phagocytosis, modulate inflammation, and regulate allergic responses. SP-B/SP-C are structural.
5. Supports Gas Exchange: By keeping alveoli open and stable, surfactant optimizes the ventilation-perfusion match for efficient O₂/CO₂ exchange.
6. Critical for Neonates: Surfactant production ramps up at 32–34 weeks gestation. Deficiency causes Neonatal Respiratory Distress Syndrome (NRDS) in preemies. Exogenous surfactant replacement (beractant, poractant alfa, calfactant) is lifesaving—reduces mortality, pneumothorax, BPD.

Clinical Relevance

• ARDS: Surfactant inactivation/depletion contributes to pathophysiology; exogenous trials show mixed results.
• Mechanical ventilation: Volutrauma/barotrauma damages type II cells → surfactant dysfunction.
• Genetic mutations (SFTPB, SFTPC, ABCA3) → rare, fatal neonatal surfactant deficiency.

Surfactant is the lung's "linchpin"—without it, breathing is unsustainable.